SSRI withdrawal
Mareth, T.R.; Brown, T.M.
Journal of Clinical Psychiatry 57(7): 310
1996
ISSN/ISBN: 0160-6689 PMID: 8666577 Document Number: 463970
Document emailed within 1 workday
Related Documents
Komiyama, T. 1997: Clinical features of alcoholics after alcohol withdrawal--withdrawal syndrome, protracted withdrawal syndrome and prolonged disturbance of alcohol dependence Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 393-405Levy, R.; le Maignan, C.; N'Daw, D.; Andrieu, J.M. 1997: An equivalent of anti-androgen withdrawal syndrome: decrease of prostate specific antigen and clinical response to estramustine phosphate withdrawal Presse Medicale 26(13): 611
Hofmann, M.; Vidoni, F. 1996: SSRI-induced akathesia Psychiatrische Praxis 23(3): 143-144
Bjerre, J. 2014: Danish SSRi deficiency or ...? Ugeskrift for Laeger 176(3): 275
Monji, A.; Yanagimoto, K.; Yoshida, I.; Hashioka, S. 2004: SSRI-induced enuresis: a case report Journal of Clinical Psychopharmacology 24(5): 564-565
Rothschild, A.J. 1995: Delirium: an SSRI-benztropine adverse effect? Journal of Clinical Psychiatry 56(11): 537
Derkacz, M.; Regan, T. 2002: The SSRi therapeutic effective dose model Managed Care 11(8 Suppl): 16-20; Discussion: 21-25
David, S. 2005: SSRi should be considered as the cause of hypoglycemias which are difficult to explain Lakartidningen 102(8): 582
2004: Neonatal complications after intrauterine exposure to SSRI antidepressants Prescrire International 13(71): 103-104
Högberg, Göran. 2008: SSRI medication to children and adolescents--caution is recommended Lakartidningen 105(1-2): 52
2004: Extrapyramidal reactions to SSRI antidepressant + neuroleptic combinations Prescrire International 13(70): 57
Ninan, P.T. 2003: Obsessive-compulsive disorder: implications of the efficacy of an SSRI, paroxetine Psychopharmacology Bulletin 37(Suppl 1): 89-96
Gönül, A.S.; Aksu, M. 1999: SSRI-induced parkinsonism may be an early sign of future Parkinson's disease Journal of Clinical Psychiatry 60(6): 410
Zdanowicz, N.; Reynaert, C.; Jacques, D.; Lepiece, B.; Dubois, T. 2017: Selective Serotonergic (SSRI) Versus Noradrenergic (SNRI) Reuptake Inhibitors with and without Acetylsalicylic Acid in Major Depressive Disorder Psychiatria Danubina 29(Suppl 3): 270-273
Ortayli, N.; Bulut, A.şe.; Ozugurlu, M.; Cokar, M. 2005: Why withdrawal? Why not withdrawal? Men's perspectives Reproductive Health Matters 13(25): 164-173
Isacsson, G.ör.; Bejerot, S.; Jarbin, H.åk. 2007: Fewer children are treated with SSRI, more commit suicide. Alarming trend among children and adolescents in USA Lakartidningen 104(43): 3180-3181
Thomas, K.L.H.; Ellingrod, V.L.; Bishop, J.R.; Keiser, M.J. 2010: A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach Psychopharmacology Bulletin 43(1): 11-22
Bishop, J.R.; Ellingrod, V.L.; Akroush, M.; Moline, J. 2009: The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives Human Psychopharmacology 24(3): 207-215
Jantz, L.L. 1977: Withdrawal, healing, and prevention of recurrence. Methods, possibilities and prognosis of withdrawal, healing, and recurrence prevention in alcoholics Zfa. Zeitschrift für Allgemeinmedizin 53(26): 1538-1543
2009: Desvenlafaxine: application withdrawal. Desvenlafaxine: withdrawal of marketing application for depression also Prescrire International 18(103): 197